Consolidated Balance Sheets

2011 Annual Report

December 31,

(In millions, except per share data)

2011

2010

Assets

Current assets:

Cash and cash equivalents

$2,201.6 $1,788.8
Investments available-for-sale, at fair value:

 

 

Fixed maturity securities (amortized cost of $15,233.6 and $15,545.4)

15,913.1 16,069.5

Equity securities (cost of $937.7 and $861.4)

1,188.1 1,236.2

Other invested assets, current

14.8 21.1

Accrued investment income

172.0 177.4

Premium and self-funded receivables

3,402.9 3,041.6

Other receivables

943.9 878.6

Income taxes receivable

105.8 32.3

Securities lending collateral

871.4 900.3

Deferred tax assets, net

424.8 460.9

Other current assets

1,859.0 1,534.1

Total current assets

27,097.4 26,140.8

Long-term investments available-for-sale, at fair value:

Fixed maturity securities (amortized cost of $240.8 and $215.8)

246.8 221.8

Equity securities (cost of $28.4 and $32.8)

28.8 33.4

Other invested assets, long-term

1,003.7 865.4

Property and equipment, net

1,418.1 1,155.5

Goodwill

13,858.7 13,264.9

Other intangible assets

7,931.7 7,996.8

Other noncurrent assets

433.6 488.3

Total assets

$52,018.8

$50,166.9

 

 

 

Liabilities and shareholders’ equity

 

 

Liabilities

 

 

Current liabilities:

 

 

Policy liabilities:

 

 

Medical claims payable

$5,489.0

$4,852.4

Reserves for future policy benefits

55.1

56.4

Other policyholder liabilities

2,278.2

1,909.1

Total policy liabilities

7,822.3

6,817.9

Unearned income

926.5

891.4

Accounts payable and accrued expenses

3,124.1

2,942.2

Security trades pending payable

51.7

33.3

Securities lending payable

872.5

901.5

Short-term borrowings

100.0

100.0

Current portion of long-term debt

1,274.5

705.9

Other current liabilities

1,654.1

1,617.3

Total current liabilities

15,825.7

14,009.5

Long-term debt, less current portion

8,420.9

8,147.8

Reserves for future policy benefits, noncurrent

730.7

646.7

Deferred tax liabilities, net

2,724.0

2,586.9

Other noncurrent liabilities

1,029.3

963.4

Total liabilities

28,730.6

26,354.3

Commitments and contingencies—Note 14

 

 

Shareholders’ equity

 

 

Preferred stock, without par value, shares authorized—100,000,000;

 

 

shares issued and outstanding—none

Common stock, par value $0.01, shares authorized—900,000,000;

 

 

shares issued and outstanding: 339,372,680 and 377,736,929

3.4

3.8

Additional paid-in capital

11,679.2

12,862.6

Retained earnings

11,490.7

10,721.6

Accumulated other comprehensive income

114.9

224.6

Total shareholders’ equity

23,288.2

23,812.6

 

 

 

Total liabilities and shareholders’ equity

$52,018.8

$50,166.9

The information presented above should be read in conjunction with the audited financial statements and accompanying notes included in WellPoint’s 2011 Annual Report on Form 10-K.